10a-azalide compound having 4-membered ring structure
US8299035B2 · kind B2 · utility
0Cited by
5References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 15, 2009 |
| Grant date | Oct 30, 2012 |
| Priority date | — |
| Expiry date | May 15, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A 10a-azalide compound having a 4-membered ring structure crosslinked at the 10a- and 12-positions, which is represented by the formula (I), and is effective on even Haemophilus influenzae, or erythromycin resistant bacteria (e.g., resistant pneunococci and streptococci).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.